EASD 2020 Highlights Podcast Presented ByDr Rachel Giles, Medicom ConferenceEASD 2020 8 December 2020 15:44
Ertugliflozin offers some kidney protection Presented ByProf. David Cherney, University of Toronto, Canada TrialVERTIS CV ConferenceEASD 2020 TypeNews article 14 December 2020 12:44
DAPA-CKD trial shows extensive benefits of dapagliflozin Presented ByProf. Hiddo Heerspink, University of Groningen, the Netherlands TrialDAPA-CKD ConferenceEASD 2020 TypeNews article 14 December 2020 12:42
Empagliflozin significantly reduces CV and renal risk Presented ByDr Milton Packer, Baylor University Medical Center, Dallas, USA TrialEMPEROR-Reduced ConferenceEASD 2020 TypeNews article 14 December 2020 12:40
Poor prognosis for T2D patients on loop diuretics in addition to SGLT2 inhibitor Presented ByProf. Pierpaolo Pellicori, University of Glasgow, United Kingdom TrialEMPA-REG OUTCOME ConferenceEASD 2020 TypeNews article 14 December 2020 12:39
Once daily oral treatment with glucokinase activator TTP399 reduced HbA1c in patients with type 1 diabetes TrialSimplici-T1 ConferenceEASD 2020 TypeNews article 14 December 2020 12:38
High risk of vascular dementia in patients with T2D Presented ByDr Carlos Celis-Morales, University of Glasgow, Scotland ConferenceEASD 2020 TypeNews article 14 December 2020 12:36
HbA1c reduction with GLP-1RA leads to lower risk of CV events in cardiovascular outcome trials Presented ByDr Mart Roosimaa , University of Tartu, Estonia ConferenceEASD 2020 TypeNews article 14 December 2020 12:35
Diabetes still goes unnoticed, resulting in delayed diagnosis Presented ByDr Katie Young, University of Exeter Medical School, United Kingdom ConferenceEASD 2020 TypeNews article 14 December 2020 12:34
Shared pathways for COVID-19 and diabetes? ConferenceEASD 2020 TypeNews article 14 December 2020 12:32
Patients with RA have higher risk of developing diabetes Presented ByDr Zixing Tian, University of Manchester, United Kingdom ConferenceEASD 2020 TypeNews article 14 December 2020 12:31
Once-weekly insulin is a promising treatment option Presented ByDr Julio Rosenstock, University of Texas Southwestern, USA TrialPhase 2 ConferenceEASD 2020 TypeNews article 14 December 2020 12:29
Non-invasive monitoring by measuring glycated albumin in tears Presented ByDr Masakazu Aihara, University of Tokyo, Japan ConferenceEASD 2020 TypeNews article 14 December 2020 12:28
More exercise means less risk of all-cause mortality amongst T2D patients. Presented ByDr Yun-Ju Lai , Taichung Veterans General Hospital, Taiwan ConferenceEASD 2020 TypeNews article 14 December 2020 12:27
Intermittent fasting: consuming fewer calories but in a different way. Presented ByProf. Krista Varady, University of Illinois, Chicago, USA ConferenceEASD 2020 TypeNews article 14 December 2020 12:24
Timing of mealtime insulin can affect quality of life ConferenceEASD 2020 TypeNews article 14 December 2020 12:22